{"filing":{"accession_number":"0001213900-26-091720","cik":"0001468492","ticker":"HSCSW","company_name":"HeartSciences Inc.","form":"8-K","filing_date":"2026-08-19","report_date":"2026-08-19","primary_document":"ea0302763-8k_heart.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1468492/000121390026091720/ea0302763-8k_heart.htm"},"events":[{"id":28572,"run_id":26143,"accession_number":"0001213900-26-091720","anchor_item_number":"7.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"HeartSciences issued 411,522 shares of common stock to Fortitude Mining Holdings in a private placement at $2.43 per share for approximately $1 million on August 12, 2026. This is a classic dilutive equity issuance in connection with a proposed business combination. The filing explicitly describes it as a \"private placement\" and notes that Fortitude now holds approximately 9.4% of HeartSciences' outstanding shares. While the transaction is also related to an ongoing M\u0026A activity (the proposed merger with Fortitude), the primary disclosed event is the equity issuance itself, which is material to existing shareholders due to dilution.","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-08-19","form":"8-K","submitted_at":null,"items":[{"id":30564,"accession_number":"0001213900-26-091720","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"HeartSciences issued 411,522 shares of common stock to Fortitude Mining Holdings in a private placement at $2.43 per share for approximately $1 million on August 12, 2026. This is a classic dilutive equity issuance in connection with a proposed business combination. The filing explicitly describes it as a \"private placement\" and notes that Fortitude now holds approximately 9.4% of HeartSciences' outstanding shares. While the transaction is also related to an ongoing M\u0026A activity (the proposed merger with Fortitude), the primary disclosed event is the equity issuance itself, which is material to existing shareholders due to dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T20:47:42.899645+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30564,"accession_number":"0001213900-26-091720","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"HeartSciences issued 411,522 shares of common stock to Fortitude Mining Holdings in a private placement at $2.43 per share for approximately $1 million on August 12, 2026. This is a classic dilutive equity issuance in connection with a proposed business combination. The filing explicitly describes it as a \"private placement\" and notes that Fortitude now holds approximately 9.4% of HeartSciences' outstanding shares. While the transaction is also related to an ongoing M\u0026A activity (the proposed merger with Fortitude), the primary disclosed event is the equity issuance itself, which is material to existing shareholders due to dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-19T20:47:42.899645+00:00","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-08-19"}]}